Purification and amino acid analysis of two human glioma-derived monocyte chemoattractants
暂无分享,去创建一个
[1] J. Pontén,et al. Long term culture of normal and neoplastic human glia. , 2009, Acta pathologica et microbiologica Scandinavica.
[2] E. Appella,et al. Purification and amino acid analysis of two human monocyte chemoattractants produced by phytohemagglutinin-stimulated human blood mononuclear leukocytes. , 1989, Journal of immunology.
[3] J. Kuratsu,et al. Production and characterization of human glioma cell-derived monocyte chemotactic factor. , 1989, Journal of the National Cancer Institute.
[4] J. Shabanowitz,et al. Complete amino acid sequence of a human monocyte chemoattractant, a putative mediator of cellular immune reactions. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[5] E. Appella,et al. Human monocyte chemoattractant protein‐1 (MCP‐1) Full‐length cDNA cloning, expression in mitogen‐stimulated blood mononuclear leukocytes, and sequence similarity to mouse competence gene JE , 1989, FEBS letters.
[6] A. Mantovani,et al. Induction of monocyte migration by recombinant macrophage colony-stimulating factor. , 1988, Journal of immunology.
[7] R. Derynck,et al. Molecular characterization and chromosomal mapping of melanoma growth stimulatory activity, a growth factor structurally related to beta‐thromboglobulin. , 1988, The EMBO journal.
[8] L M Wakefield,et al. Transforming growth factor type beta induces monocyte chemotaxis and growth factor production. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[9] A. Mantovani,et al. Chemotactic factor and P15E-related chemotaxis inhibitor in human melanoma cell lines with different macrophage content and tumorigenicity in nude mice. , 1987, Journal of immunology.
[10] P. Allavena,et al. Chemotactic activity of human recombinant granulocyte-macrophage colony-stimulating factor. , 1987, Immunology.
[11] A. Mantovani,et al. Tumor necrosis factor is chemotactic for monocytes and polymorphonuclear leukocytes. , 1987, Journal of immunology.
[12] A. Mantovani,et al. Coexistence of a chemotactic factor and a retroviral P15E-related chemotaxis inhibitor in human tumor cell culture supernatants. , 1986, Journal of immunology.
[13] I. Fidler. Macrophages and metastasis--a biological approach to cancer therapy. , 1985, Cancer research.
[14] A. Mantovani,et al. Tumor‐derived chemotactic factor(S) from human ovarian carcinoma: Evidence for a role in the regulation of macrophage content of neoplastic tissues , 1985, International journal of cancer.
[15] A. J. Valente,et al. Initial characterization of a peripheral blood mononuclear cell chemoattractant derived from cultured arterial smooth muscle cells. , 1984, The American journal of pathology.
[16] N. de Tribolet,et al. Glioblastoma cells release interleukin 1 and factors inhibiting interleukin 2-mediated effects. , 1984, Journal of immunology.
[17] C. Heldin,et al. A glioma-derived analog to platelet-derived growth factor: demonstration of receptor competing activity and immunological crossreactivity. , 1984, Proceedings of the National Academy of Sciences of the United States of America.
[18] T. Luger,et al. Chemotactic properties of partially purified human epidermal cell-derived thymocyte-activating factor (ETAF) for polymorphonuclear and mononuclear cells. , 1983, Journal of immunology.
[19] A. Mantovani,et al. Regulation of the macrophage content of neoplasms by chemoattractants. , 1983, Science.
[20] A. Mantovani,et al. Chemotactic activity for mononuclear phagocytes of culture supernatants from murine and human tumor cells: Evidence for a role in the regulation of the macrophage content of neoplastic tissues , 1983, International journal of cancer.
[21] E. Leonard,et al. Effects of cell concentration on chemotactic responsiveness of mouse resident peritoneal macrophages. , 1981, Journal of the Reticuloendothelial Society.
[22] W. Falk,et al. A 48-well micro chemotaxis assembly for rapid and accurate measurement of leukocyte migration. , 1980, Journal of immunological methods.
[23] M. Meltzer,et al. Macrophage activation for tumor cytotoxicity: development of macrophage cytotoxic activity requires completion of a sequence of short-lived intermediary reactions. , 1978, Journal of immunology.
[24] M. Meltzer,et al. Characterization of macrophage chemotaxins in tumor cell cultures and comparison with lymphocyte-derived chemotactic factors. , 1977, Cancer research.
[25] B. Mackler,et al. Physicochemical characterization of chemotatic lymphokines produced by human T and B lymphocytes. , 1975, Journal of immunology.
[26] R. Snyderman,et al. Human mononuclear leukocyte chemotaxis: a quantitative assay for humoral and cellular chemotactic factors. , 1972, Journal of immunology.
[27] U. K. Laemmli,et al. Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 , 1970, Nature.
[28] P. Ward,et al. The production by antigen-stimulated lymphocytes of a leukotactic factor distinct from migration inhibitory factor. , 1970, Cellular immunology.
[29] B. Zbar,et al. Tumor-graft rejection in syngeneic guinea pigs: evidence for a two-step mechanism. , 1970, Journal of the National Cancer Institute.
[30] S. Haskill,et al. Activities of macrophages within and peripheral to the tumor mass. , 1983 .
[31] D. B. Amos,et al. THE MACROPHAGE AS A TUMORICIDAL EFFECTOR CELL: A REVIEW OF IN VIVO AND IN VITRO STUDIES ON THE MECHANISM OF THE ACTIVATED MACROPHAGE NONSPECIFIC CYTOTOXIC REACTION * , 1976 .